Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-124664
Filing Date
2024-11-12
Accepted
2024-11-12 08:33:04
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pali-20240930.htm   iXBRL 10-Q 1935815
2 EX-31.1 pali-ex31_1.htm EX-31.1 16147
3 EX-31.2 pali-ex31_2.htm EX-31.2 16378
4 EX-32.1 pali-ex32_1.htm EX-32.1 10245
  Complete submission text file 0000950170-24-124664.txt   6921684

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pali-20240930.xsd EX-101.SCH 959802
59 EXTRACTED XBRL INSTANCE DOCUMENT pali-20240930_htm.xml XML 1037771
Mailing Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009
Business Address 7750 EL CAMINO REAL, SUITE 5200 CARLSBAD CA 92009 (858) 704-4900
PALISADE BIO, INC. (Filer) CIK: 0001357459 (see all company filings)

EIN.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33672 | Film No.: 241443754
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)